DK1664767T3 - Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter - Google Patents
Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukterInfo
- Publication number
- DK1664767T3 DK1664767T3 DK04774922T DK04774922T DK1664767T3 DK 1664767 T3 DK1664767 T3 DK 1664767T3 DK 04774922 T DK04774922 T DK 04774922T DK 04774922 T DK04774922 T DK 04774922T DK 1664767 T3 DK1664767 T3 DK 1664767T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- biological profile
- determining
- group
- impact
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Theoretical Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03077804A EP1512970A1 (en) | 2003-09-05 | 2003-09-05 | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| PCT/NL2004/000616 WO2005024420A1 (en) | 2003-09-05 | 2004-09-03 | Method for determining the impact of a multicomponent natural product mixture on the biological profile of a disease within a group of living systems and the development and quality control of natural product based medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664767T3 true DK1664767T3 (da) | 2008-03-25 |
Family
ID=34130247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070020180A1 (da) |
| EP (3) | EP1512970A1 (da) |
| JP (2) | JP4675896B2 (da) |
| CN (2) | CN1875273A (da) |
| AT (2) | ATE378593T1 (da) |
| DE (2) | DE602004010155T2 (da) |
| DK (2) | DK1664770T3 (da) |
| EA (1) | EA011959B1 (da) |
| ES (2) | ES2297475T3 (da) |
| WO (2) | WO2005024420A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| US7729789B2 (en) * | 2004-05-04 | 2010-06-01 | Fisher-Rosemount Systems, Inc. | Process plant monitoring based on multivariate statistical analysis and on-line process simulation |
| US20080183101A1 (en) * | 2006-08-17 | 2008-07-31 | Jonathan Richard Stonehouse | Salivary analysis |
| JP5491377B2 (ja) * | 2007-03-30 | 2014-05-14 | ９８９８リミテッド | 天然物開発のための薬剤プラットフォーム技術 |
| DE102008011013B4 (de) * | 2008-02-25 | 2014-11-13 | Mevitec Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
| KR101144237B1 (ko) * | 2009-12-29 | 2012-05-11 | 한국기초과학지원연구원 | 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법 |
| SG193006A1 (en) * | 2011-03-02 | 2013-10-30 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| AU2012376214B2 (en) | 2012-04-02 | 2019-02-14 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| JP2014020831A (ja) * | 2012-07-13 | 2014-02-03 | Kyoto Univ | 混合物試料の属性を識別する方法及び装置 |
| EP3017300A4 (en) * | 2013-07-01 | 2017-03-08 | Ixcela, Inc. | Systems biology approach to therapy |
| WO2016039348A1 (ja) * | 2014-09-10 | 2016-03-17 | 一般財団法人ニッセンケン品質評価センター | タンパク質繊維の鑑別方法 |
| NZ730197A (en) | 2014-09-11 | 2022-07-01 | Berg Llc | Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data |
| CN109115904B (zh) * | 2018-07-25 | 2021-02-02 | 山西广誉远国药有限公司 | 一种定坤丹uplc指纹图谱的构建方法及其应用 |
| EP4010456A4 (en) | 2019-08-05 | 2023-09-13 | Seer, Inc. | SYSTEMS AND METHODS FOR SAMPLE PREPARATION, DATA GENERATION AND ANALYSIS OF CORONA PROTEIN |
| CN111180007A (zh) * | 2019-12-03 | 2020-05-19 | 深圳市开物成务中医药科技有限公司 | 一种安全、有效、高质量中药开发平台系统及实现方法 |
| CN111060640A (zh) * | 2019-12-27 | 2020-04-24 | 深圳市开物成务中医药科技有限公司 | 测定与胰岛素耐受性相关的血脂谱的方法、应用及装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US5563043A (en) * | 1994-10-24 | 1996-10-08 | Spiral Biotech, Inc. | Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| US6379714B1 (en) * | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| WO1997020076A1 (en) * | 1995-11-29 | 1997-06-05 | Nexstar Pharmaceuticals, Inc. | Methods for optimizing multicomponent formulations |
| JP3978529B2 (ja) * | 1998-08-03 | 2007-09-19 | 大正製薬株式会社 | 冬虫夏草の判別法 |
| US20030044846A1 (en) * | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
| EP1263988A2 (en) * | 2000-03-09 | 2002-12-11 | Yale University | Phytomics: a genomic-based approach to herbal compositions |
| US20020095260A1 (en) * | 2000-11-28 | 2002-07-18 | Surromed, Inc. | Methods for efficiently mining broad data sets for biological markers |
| US8068987B2 (en) * | 2001-08-13 | 2011-11-29 | Bg Medicine, Inc. | Method and system for profiling biological systems |
| TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| EP1842065B1 (en) * | 2005-01-28 | 2010-12-01 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of bladder cancer |
-
2003
- 2003-09-05 EP EP03077804A patent/EP1512970A1/en not_active Withdrawn
-
2004
- 2004-09-03 DK DK04774923T patent/DK1664770T3/da active
- 2004-09-03 JP JP2006525291A patent/JP4675896B2/ja not_active Expired - Fee Related
- 2004-09-03 AT AT04774922T patent/ATE378593T1/de active
- 2004-09-03 US US10/570,505 patent/US20070020180A1/en not_active Abandoned
- 2004-09-03 DK DK04774922T patent/DK1664767T3/da active
- 2004-09-03 JP JP2006525292A patent/JP2007508603A/ja active Pending
- 2004-09-03 AT AT04774923T patent/ATE378594T1/de active
- 2004-09-03 WO PCT/NL2004/000616 patent/WO2005024420A1/en active IP Right Grant
- 2004-09-03 WO PCT/NL2004/000617 patent/WO2005024421A1/en active IP Right Grant
- 2004-09-03 DE DE602004010155T patent/DE602004010155T2/de not_active Expired - Lifetime
- 2004-09-03 CN CNA2004800324024A patent/CN1875273A/zh active Pending
- 2004-09-03 EA EA200600539A patent/EA011959B1/ru not_active IP Right Cessation
- 2004-09-03 EP EP04774922A patent/EP1664767B1/en not_active Expired - Lifetime
- 2004-09-03 ES ES04774922T patent/ES2297475T3/es not_active Expired - Lifetime
- 2004-09-03 DE DE602004010154T patent/DE602004010154T2/de not_active Expired - Lifetime
- 2004-09-03 CN CNA2004800325525A patent/CN1875274A/zh active Pending
- 2004-09-03 ES ES04774923T patent/ES2297476T3/es not_active Expired - Lifetime
- 2004-09-03 EP EP04774923A patent/EP1664770B1/en not_active Expired - Lifetime
- 2004-09-03 US US10/571,087 patent/US20070160990A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004010154D1 (de) | 2007-12-27 |
| CN1875274A (zh) | 2006-12-06 |
| DE602004010155D1 (de) | 2007-12-27 |
| CN1875273A (zh) | 2006-12-06 |
| WO2005024421A1 (en) | 2005-03-17 |
| ATE378594T1 (de) | 2007-11-15 |
| EA011959B1 (ru) | 2009-06-30 |
| ES2297476T3 (es) | 2008-05-01 |
| US20070020180A1 (en) | 2007-01-25 |
| DE602004010155T2 (de) | 2008-09-25 |
| WO2005024420A1 (en) | 2005-03-17 |
| DK1664770T3 (da) | 2008-03-25 |
| JP4675896B2 (ja) | 2011-04-27 |
| EP1664767B1 (en) | 2007-11-14 |
| EP1664770B1 (en) | 2007-11-14 |
| EP1664767A1 (en) | 2006-06-07 |
| ATE378593T1 (de) | 2007-11-15 |
| JP2007510132A (ja) | 2007-04-19 |
| ES2297475T3 (es) | 2008-05-01 |
| DE602004010154T2 (de) | 2008-09-25 |
| EP1512970A1 (en) | 2005-03-09 |
| EP1664770A1 (en) | 2006-06-07 |
| US20070160990A1 (en) | 2007-07-12 |
| EA200600539A1 (ru) | 2006-08-25 |
| JP2007508603A (ja) | 2007-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1664767T3 (da) | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter | |
| CY1120670T1 (el) | Μονοκλωνικα αντισωματα εναντι του αναστολεα μονοπατιου ιστικου παραγοντα (tfpi) | |
| ATE534650T1 (de) | Neue cyanothiazolide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE507224T1 (de) | Verfahren und zwischenverbindungen zur herstellung von n4-phenyl-quinazolin-4-amin derivaten | |
| ATE463294T1 (de) | Verfahren zur konzentration und reinigung von biologischen verbindungen | |
| CY1114701T1 (el) | Συνθεσεις και μεθοδοι για αυξηση ασβεστοποιησης οστων | |
| ATE533358T1 (de) | Verfahren zum kontrollieren von schädlingen mittels rnai | |
| ATE490984T1 (de) | Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern | |
| ATE488251T1 (de) | Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen | |
| EA201000245A1 (ru) | Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf | |
| EA200501676A1 (ru) | Фосфонатсодержащие ингибиторы киназы (варианты), способ их получения, фармацевтическая композиция, лекарственная форма на их основе и способ ингибирования киназы у млекопитающего (варианты) | |
| BRPI0513029A (pt) | método para produzir uma proteìna de eritropoietina carbamilada, proteìna de eritropoietina carbamilada, composto, composição farmacêutica, métodos de tratamento de uma doença ou condição crÈnica, sub-crÈnica e aguda e de tratamento de uma doença do sistema nervoso central ou sistema nervoso periférico, e, uso de um composto | |
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| ATE445569T1 (de) | Verfahren und vorrichtung zur herstellung von synergistischem biozid | |
| BRPI0615691A8 (pt) | Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo | |
| DE602006008583D1 (de) | Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung | |
| ATE446299T1 (de) | Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin | |
| ATE435026T1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| DK1604203T3 (da) | Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter | |
| HK1087417A1 (en) | Method and apparatus for continuous large-scale radiolabeling of proteins | |
| ATE323539T1 (de) | Chromatographie-verfahren und vorrichtung welche einen konzentrations-schritt integrieren | |
| ATE461693T1 (de) | Verfahren zur behandlung von akuten rhinosinusitis | |
| DE69824839D1 (de) | Verfahren zur herstellung von 2-aryl-3-aryl-5-halogen-pyridinen, verwendbar als cox-2 inhibitoren | |
| ATE463476T1 (de) | Verfahren zur herstellung von acrysäure und polymerisierbare verbindungen |